Viewing Study NCT07301268

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-01-29 @ 10:55 PM
Study NCT ID: NCT07301268
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: GI-102 Alone or in Combination With Pembrolizumab Before Surgery for the Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma, IDH-Wildtype View
None Progressive Astrocytoma, IDH-Mutant, Grade 4 View
None Progressive Glioblastoma View
None Progressive Gliosarcoma View
None Recurrent Astrocytoma, IDH-Mutant, Grade 4 View
None Recurrent Glioblastoma, IDH-Wildtype View
None Recurrent Gliosarcoma View
None Resectable Astrocytoma View
None Resectable Glioblastoma View
Keywords: